Skip to main content
×
Home

Calcium supplements and cancer risk: a meta-analysis of randomised controlled trials

  • Sarah M. Bristow (a1), Mark J. Bolland (a1), Graeme S. MacLennan (a2), Alison Avenell (a2), Andrew Grey (a1), Greg D. Gamble (a1) and Ian R. Reid (a1)...
Abstract

Some evidence suggests that Ca and vitamin D supplements affect cancer risk; however, it is uncertain whether the effects are due to Ca, vitamin D or the combination. We investigated the effect of Ca supplements without co-administered vitamin D on cancer risk. Medline, Embase and the Cochrane Central Register of Controlled Trials, reference lists of meta-analyses and two clinical trial registries were searched for randomised, placebo-controlled trials of Ca supplements ( ≥ 500 mg/d), with ≥ 100 participants and duration >1 year. The lead authors of eligible trials supplied data on cancer outcomes. Trial-level data were analysed using random-effects meta-analyses and patient-level data using Cox proportional hazards models. A total of sixteen trials were eligible, six had no data available, ten provided trial-level data (n 10 496, mean duration 3·9 years), and of these, four provided patient-level data (n 7221, median duration 3·5 years). In the meta-analysis of trial-level data, allocation to Ca did not alter the risk of total cancer (relative risk 0·95, 95 % CI 0·76, 1·18, P= 0·63), colorectal cancer (relative risk 1·38, 95 % CI 0·89, 2·15, P= 0·15), breast cancer (relative risk 1·01, 95 % CI 0·64, 1·59, P= 0·97) or cancer-related mortality (relative risk 0·96, 95 % CI 0·74, 1·24, P= 0·75), but reduced the risk of prostate cancer (relative risk 0·54, 95 % CI 0·30, 0·96, P= 0·03), although there were few events. The meta-analysis of patient-level data showed similar results, with no effect of Ca on the risk of total cancer (hazard ratio 1·07, 95 % CI 0·89, 1·28, P= 0·50). Ca supplements without co-administered vitamin D did not alter total cancer risk over 4 years, although the meta-analysis lacked power to detect very small effects, or those with a longer latency.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Calcium supplements and cancer risk: a meta-analysis of randomised controlled trials
      Available formats
      ×
      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your Dropbox account. Find out more about sending content to Dropbox.

      Calcium supplements and cancer risk: a meta-analysis of randomised controlled trials
      Available formats
      ×
      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your Google Drive account. Find out more about sending content to Google Drive.

      Calcium supplements and cancer risk: a meta-analysis of randomised controlled trials
      Available formats
      ×
Copyright
Corresponding author
*Corresponding author: M. J. Bolland, fax +64 9 373 7677, email m.bolland@auckland.ac.nz
References
Hide All
1Garland C, Shekelle RB, Barrett-Connor E, et al. (1985) Dietary vitamin D and calcium and risk of colorectal cancer: a 19-year prospective study in men. Lancet i, 307309.
2Kampman E, Slattery ML, Caan B, et al. (2000) Calcium, vitamin D, sunshine exposure, dairy products and colon cancer risk (United States). Cancer Causes Control 11, 459466.
3Wu K, Willett WC, Fuchs CS, et al. (2002) Calcium intake and risk of colon cancer in women and men. J Natl Cancer Inst 94, 437446.
4Shin MH, Holmes MD, Hankinson SE, et al. (2002) Intake of dairy products, calcium, and vitamin D and risk of breast cancer. J Natl Cancer Inst 94, 13011311.
5McCullough ML, Rodriguez C, Diver WR, et al. (2005) Dairy, calcium, and vitamin D intake and postmenopausal breast cancer risk in the Cancer Prevention Study II Nutrition Cohort. Cancer Epidemiol Biomarkers Prev 14, 28982904.
6Giovannucci E, Rimm EB, Wolk A, et al. (1998) Calcium and fructose intake in relation to risk of prostate cancer. Cancer Res 58, 442447.
7Chan JM, Giovannucci E, Andersson SO, et al. (1998) Dairy products, calcium, phosphorous, vitamin D, and risk of prostate cancer (Sweden). Cancer Causes Control 9, 559566.
8Chan JM, Stampfer MJ, Ma J, et al. (2001) Dairy products, calcium, and prostate cancer risk in the Physicians' Health Study. Am J Clin Nutr 74, 549554.
9Kearney J, Giovannucci E, Rimm EB, et al. (1996) Calcium, vitamin D, and dairy foods and the occurrence of colon cancer in men. Am J Epidemiol 143, 907917.
10Martinez ME, Giovannucci EL, Colditz GA, et al. (1996) Calcium, vitamin D, and the occurrence of colorectal cancer among women. J Natl Cancer Inst 88, 13751382.
11Larsson SC, Bergkvist L & Wolk A (2009) Long-term dietary calcium intake and breast cancer risk in a prospective cohort of women. Am J Clin Nutr 89, 277282.
12Park SY, Murphy SP, Wilkens LR, et al. (2007) Calcium, vitamin D, and dairy product intake and prostate cancer risk: the Multiethnic Cohort Study. Am J Epidemiol 166, 12591269.
13Park Y, Mitrou PN, Kipnis V, et al. (2007) Calcium, dairy foods, and risk of incident and fatal prostate cancer: the NIH-AARP Diet and Health Study. Am J Epidemiol 166, 12701279.
14Anderson L, Cotterchio M, Vieth R, et al. (2010) Vitamin D and calcium intakes and breast cancer risk in pre- and postmenopausal women. Am J Clin Nutr 91, 16991707.
15Lappe JM, Travers-Gustafson D, Davies KM, et al. (2007) Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am J Clin Nutr 85, 15861591.
16Avenell A, Maclennan GS, Jenkinson DJ, et al. (2012) Long-term follow-up for mortality and cancer in a randomized placebo-controlled trial of vitamin D3 and/or calcium (RECORD Trial). J Clin Endocrinol Metab 97, 614622.
17Chlebowski RT, Johnson KC, Kooperberg C, et al. (2008) Calcium plus vitamin D supplementation and the risk of breast cancer. J Natl Cancer Inst 100, 15811591.
18Wactawski-Wende J, Kotchen JM, Anderson GL, et al. (2006) Calcium plus vitamin D supplementation and the risk of colorectal cancer. N Engl J Med 354, 684696.
19Bolland MJ & Reid IR (2008) Calcium supplementation and cancer incidence. Am J Clin Nutr 87, 792793(author reply 793–794).
20Bolland MJ, Grey A, Gamble GD, et al. (2011) Calcium and vitamin D supplements and health outcomes: a reanalysis of the Women's Health Initiative (WHI) limited-access data set. Am J Clin Nutr 94, 11441149.
21Bolland MJ, Avenell A, Baron JA, et al. (2010) Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis. BMJ 341, c3691.
22Reid IR, Ames RW, Evans MC, et al. (1993) Effect of calcium supplementation on bone loss in postmenopausal women. N Engl J Med 328, 460464.
23Baron JA, Beach M, Mandel JS, et al. (1999) Calcium supplements for the prevention of colorectal adenomas. Calcium Polyp Prevention Study Group. N Engl J Med 340, 101107.
24Bonnick S, Broy S, Kaiser F, et al. (2007) Treatment with alendronate plus calcium, alendronate alone, or calcium alone for postmenopausal low bone mineral density. Curr Med Res Opin 23, 13411349.
25Grant AM, Avenell A, Campbell MK, et al. (2005) Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomised Evaluation of Calcium Or vitamin D, RECORD): a randomised placebo-controlled trial. Lancet 365, 16211628.
26Reid IR, Mason B, Horne A, et al. (2006) Randomized controlled trial of calcium in healthy older women. Am J Med 119, 777785.
27Reid IR, Ames R, Mason B, et al. (2008) Randomized controlled trial of calcium supplementation in healthy, nonosteoporotic, older men. Arch Intern Med 168, 22762282.
28Bonithon-Kopp C, Kronborg O, Giacosa A, et al. (2000) Calcium and fibre supplementation in prevention of colorectal adenoma recurrence: a randomised intervention trial. European Cancer Prevention Organisation Study Group. Lancet 356, 13001306.
29Chailurkit LO, Saetung S, Thakkinstian A, et al. (2010) Discrepant influence of vitamin D status on parathyroid hormone and bone mass after two years of calcium supplementation. Clin Endocrinol (Oxf) 73, 167172.
30Riggs BL, O'Fallon WM, Muhs J, et al. (1998) Long-term effects of calcium supplementation on serum parathyroid hormone level, bone turnover, and bone loss in elderly women. J Bone Miner Res 13, 168174.
31Peacock M, Liu G, Carey M, et al. (2000) Effect of calcium or 25OH vitamin D3 dietary supplementation on bone loss at the hip in men and women over the age of 60. J Clin Endocrinol Metab 85, 30113019.
32Smith EL, Gilligan C, Smith PE, et al. (1989) Calcium supplementation and bone loss in middle-aged women. Am J Clin Nutr 50, 833842.
33Elders PJ, Netelenbos JC, Lips P, et al. (1991) Calcium supplementation reduces vertebral bone loss in perimenopausal women: a controlled trial in 248 women between 46 and 55 years of age. J Clin Endocrinol Metab 73, 533540.
34Recker RR, Hinders S, Davies KM, et al. (1996) Correcting calcium nutritional deficiency prevents spine fractures in elderly women. J Bone Miner Res 11, 19611966.
35Prince RL, Devine A, Dhaliwal SS, et al. (2006) Effects of calcium supplementation on clinical fracture and bone structure: results of a 5-year, double-blind, placebo-controlled trial in elderly women. Arch Intern Med 166, 869875.
36Dawson-Hughes B, Dallal GE, Krall EA, et al. (1990) A controlled trial of the effect of calcium supplementation on bone density in postmenopausal women. N Engl J Med 323, 878883.
37Baron JA, Beach M, Wallace K, et al. (2005) Risk of prostate cancer in a randomized clinical trial of calcium supplementation. Cancer Epidemiol Biomarkers Prev 14, 586589.
38Schabas R (2008) Artifact in the control group undermines the conclusions of a vitamin D and cancer study. Am J Clin Nutr 87, 792(author reply 793–794).
39Manson JE, Bassuk SS, Lee IM, et al. (2012) The VITamin D and OmegA-3 TriaL (VITAL): rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease. Contemp Clin Trials 33, 159171.
40Hofstad B, Almendingen K, Vatn M, et al. (1998) Growth and recurrence of colorectal polyps: a double-blind 3-year intervention with calcium and antioxidants. Digestion 59, 148156.
41Majumdar SR, Fletcher RH & Evans AT (1999) How does colorectal cancer present? Symptoms, duration, and clues to location. Am J Gastroenterol 94, 30393045.
42Lewis JR, Zhu K & Prince RL (2011) Adverse events from calcium supplementation: relationship to errors in myocardial infarction self-reporting in randomized controlled trials of calcium supplementation. J Bone Miner Res 27, 719722.
43Sanders JL, Chattopadhyay N, Kifor O, et al. (2001) Ca(2+)-sensing receptor expression and PTHrP secretion in PC-3 human prostate cancer cells. Am J Physiol Endocrinol Metab 281, E1267E1274.
44Ritchie CK, Thomas KG, Andrews LR, et al. (1997) Effects of the calciotrophic peptides calcitonin and parathyroid hormone on prostate cancer growth and chemotaxis. Prostate 30, 183187.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

British Journal of Nutrition
  • ISSN: 0007-1145
  • EISSN: 1475-2662
  • URL: /core/journals/british-journal-of-nutrition
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Keywords:

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 29
Total number of PDF views: 365 *
Loading metrics...

Abstract views

Total abstract views: 397 *
Loading metrics...

* Views captured on Cambridge Core between September 2016 - 19th November 2017. This data will be updated every 24 hours.